Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Big Pharmas tell Fierce's London event about their ideal biotech
Dealmakers for five of the biggest pharmas shared the stage at Fierce's event in London to debate what they look for in a dream biotech partner.
Ben Adams
Nov 18, 2026 5:18am
Fierce’s London event told it could be ‘Europe’s year to shine’
Nov 17, 2026 10:00am
Biogen’s tau drug drives bigger benefits in Alzheimer’s update
Nov 18, 2026 9:26am
Clene uses Veristat’s biostatistics platform for FDA submission
Nov 18, 2026 9:00am
Pfizer buys 3 in vivo CAR-Ts in $2.6B deal with China’s Starna
Nov 18, 2026 8:30am
Vertex re-ups Genomics deal in long-running discovery pact
Nov 18, 2026 5:01am
More News
Priavoid’s Alzheimer’s pill fails to prove efficacy in ph. 2
Nov 18, 2026 4:21am
Merck axes $2.7B BTK inhibitor program after seeing ph. 3 data
Nov 18, 2026 3:11am
Fierce Pharma
Overton’s FDA nomination pulled by White House
Nov 17, 2026 9:15pm
Fierce Pharma
FDA slams China-heavy data in Summit’s ivonescimab CRL
Nov 17, 2026 4:48pm
See more stories